New cancer clinical trial: Neoadjuvant Atezolizumab With or Without Enzalutamide in Localized Prostate Cancer Given Before Radical Prostatectomy

Published on: January 29, 2019 at 12:00PM
Condition:   Prostate Adenocarcinoma
Interventions:   Drug: Atezolizumab;   Biological: Emactuzumab;   Drug: Enzalutamide
Sponsors:   University of California, San Francisco;   National Cancer Institute (NCI)
Not yet recruiting
http://bit.ly/2MHDo5l